相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PECUNIARY COMPENSATION INCREASES PARTICIPATION IN SCREENING FOR COLORECTAL CANCER
Eline Aas
HEALTH ECONOMICS (2009)
Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16,18 vaccination
Jeremy D. Goldhaber-Fiebert et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Health and economic implications of HPV vaccination in the United States
Jane J. Kim et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Assessment of the cost–effectiveness of a quadrivalent HPV vaccine in Norway using a dynamic transmission model
Erik J Dasbach et al.
Expert Review of Pharmacoeconomics & Outcomes Research (2008)
Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study
Joalim Dillner et al.
BRITISH MEDICAL JOURNAL (2008)
2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests
Thomas C. Wright et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2007)
Multiparameter calibration of a natural history model of cervical cancer
Jane J. Kim et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
Overview of the European and North American studies on HPV testing in primary cervical cancer screening
Jack Cuzick et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Clinical applications of HPV testing: A summary of meta-analyses
Marc Arbyn et al.
VACCINE (2006)
Cost-effectiveness of cervical cancer screening
Sue J. Goldie et al.
VACCINE (2006)
Cost-effectiveness analysis of liquid-based cytology and human papillomavirus testing in cervical cancer screening
Michael A. Bidus et al.
OBSTETRICS AND GYNECOLOGY (2006)
Pap smear screening in women under 30 in the Norwegian coordinated cervical cancer screening program, with a comparison of immediate biopsy vs. pap smear triage of moderate dysplasia
Jan F. Nygard et al.
ACTA CYTOLOGICA (2006)
Cost-effectiveness of extending cervical cancer screening intervals among women with prior normal pap tests
Shalini L. Kulasingam et al.
OBSTETRICS AND GYNECOLOGY (2006)
Human papillomavirus E6/E7 rnRNA expression in women younger than 30 years of age
T Molden et al.
GYNECOLOGIC ONCOLOGY (2006)
Cost-effectiveness of human papillomavirus DNA testing in the United Kingdom, The Netherlands, France, and Italy
JJ Kim et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Trends in cervical squamous cell carcinoma incidence in 13 European countries: Changing risk and the effects of screening
F Bray et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
Comparison of human papillomavirus messenger RNA and DNA detection:: A cross-sectional study of 4,136 women <30 years of age with a 2-year follow-up of high-grade squamous intraepithelial lesion
T Molden et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
Cost-effectiveness of human papillomavirus DNA testing for cervical cancer screening in women aged 30 years or more
SJ Goldie et al.
OBSTETRICS AND GYNECOLOGY (2004)
The cervical cancer epidemic that screening has prevented in the UK
J Peto et al.
LANCET (2004)
An evaluation of liquid-based cytology and human papillomavirus testing within the UK cervical cancer screening programme
C Sherlaw-Johnson et al.
BRITISH JOURNAL OF CANCER (2004)
Epidemiologic classification of human papillomavirus types associated with cervical cancer
N Muñoz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
分享论文
